Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating MG-K10 for Atopic Dermatitis has been announced, but the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MG-K10

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Atopic Dermatitis, Atopic Eczema | Phase 3 | Status: NOT_YET_RECRUITING